Source: Annual Congress 2002 - COPD - Quality of life and symptoms
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Needham, H. M. Wilkins, R. A. Stockley (Birmingham, United Kingdom). Health status changes in patients with alpha-1-antitrypsin deficiency. Eur Respir J 2002; 20: Suppl. 38, 1610

Member's Comments

No comment yet.

Related content which might interest you: Health status changes in alpha-1-antitrypsin deficiency (PiZ phenotype) over 3 years Source: Annual Congress 2003 - Alpha-1 antitrypsin deficiency and COPD Year: 2003 Health status measurements in alpha-1antitrypsin deficiency (AATD) Source: International Congress 2015 – Monitoring airway diseases with lung function tests Year: 2015 Clinical phenotypes of Italian and Spanish patients with a1-antitrypsin deficiency Source: Eur Respir J 2013; 42: 54-64 Year: 2013 Risk of cancer in individuals with severe alpha-1-antitrypsin deficiency (PiZZ) compared with the Swedish general population Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement? Year: 2020 Differences of disease phenotypes in individuals with alpha-1-antitrypsin deficiency with genotypes PiZZ and PiSZ - Analysis from the German registry Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Clinical consequences and longitudinal outcomes in PiMZ heterozygous a1-antitrypsin deficiency smokers from SPIROMICS Source: Virtual Congress 2021 – Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD Year: 2021 Clinical phenotype of individuals with common COPD investigated during the targeted detection programme for alpha1-antitrypsin deficiency in Italy Source: Annual Congress 2007 - Clinical aspects in COPD Year: 2007 Family screening in alpha1-antitrypsin deficiency Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 Prevalence of alpha1-antitrypsin deficiency and its influence on lung function decline in patients with severe asthma Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020 Occupational exposure in alpha-1-antitrypsin deficiency (AATD) Source: Annual Congress 2008 - COPD and other environment-related lung diseases Year: 2008 Correlation between annual change in health status and CT-derived lung density in subjects with alpha-1-antitrypsin deficiency Source: Eur Respir J 2003; 22: Suppl. 45, 385s Year: 2003 Health status measurement Source: Eur Respir Monogr 2013; 62: 96-104 Year: 2013 Clinical and functional characteristics of Italian and Spanish patients with alpha 1-antitrypsin deficiency Source: Annual Congress 2012 - COPD: epidemiology and varia Year: 2012 The impact of diagnostic delay on survival in alpha-1-antitrypsin deficiency - results from the Austrian Alpha-1 Lung Registry Source: Virtual Congress 2021 – What's new in respiratory problems in rare and systemic diseases Year: 2021 Erythrocyte abnormalities in alpha-1-antitrypsin deficiency (AATD) patients Source: Annual Congress 2009 - COPD: exacerbation and clinical problems Year: 2009 Decline in health status in alpha1 antitrypsin deficiency Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017 The incidence of alpha-1-antitrypsin (A1AT) deficiency alleles in Polish population – Results from the ongoing newborn screening Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making Year: 2013 Mortality in individuals with severe alpha-1-antitrypsin deficiency (PiZZ) Source: Eur Respir J 2006; 28: Suppl. 50, 144s Year: 2006 Hereditary alpha1-antitrypsin deficiency in children and its clinical consequences Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases Year: 2013